Pharma-Bio Serv, Inc. (PBSV) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
INDUSTRIAL ZONE STREET 1 DORADO, 00646 |
| State of Incorp. | |
| Fiscal Year End | October 31 |
| Industry (SIC) | 8742 - Management Consulting Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 10/31/2022 Q4 | 7/31/2022 Q3 | 4/30/2022 Q2 | 1/31/2022 Q1 | 10/31/2021 Q4 | 7/31/2021 Q3 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 14,463 | 14,239 | 13,164 | 15,352 | 16,498 | |||
| Cash and cash equivalents | 14,463 | 14,239 | 13,164 | 15,352 | 16,498 | |||
| Receivables | 4,983 | 4,803 | 5,478 | 5,046 | 10,082 | |||
| Other undisclosed current assets | 498 | 543 | 508 | 624 | 819 | |||
| Total current assets: | 19,944 | 19,585 | 19,150 | 21,022 | 27,399 | |||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 503 | 539 | 573 | 606 | 722 | |||
| Property, plant and equipment | 74 | 74 | 85 | 93 | 121 | |||
| Other noncurrent assets | 131 | 353 | 353 | 353 | ||||
| Other undisclosed noncurrent assets | 131 | |||||||
| Total noncurrent assets: | 707 | 744 | 1,011 | 1,053 | 1,196 | |||
| TOTAL ASSETS: | 20,651 | 20,329 | 20,161 | 22,074 | 28,595 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 1,630 | 1,739 | 1,512 | 1,690 | 1,811 | |||
| Accounts payable | 1,739 | 1,512 | ||||||
| Taxes payable | 1,851 | 1,851 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 1,630 | (161) | (40) | |||||
| Other undisclosed current liabilities | 478 | 420 | 679 | 632 | 550 | |||
| Total current liabilities: | 2,108 | 2,158 | 2,191 | 2,322 | 2,361 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 347 | 383 | 418 | 453 | 524 | |||
| Operating lease, liability | 347 | 383 | 418 | 453 | 524 | |||
| Other undisclosed noncurrent liabilities | 1,293 | 1,256 | 1,239 | 1,415 | 1,345 | |||
| Total noncurrent liabilities: | 1,639 | 2,022 | 2,075 | 2,322 | 2,392 | |||
| Total liabilities: | 4,093 | 4,180 | 4,267 | 4,644 | 4,754 | |||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | 16,558 | 16,149 | 15,895 | 17,431 | 23,841 | |||
| Common stock | 2 | 2 | 2 | 2 | 2 | |||
| Treasury stock, value | (502) | (500) | (491) | (475) | (394) | |||
| Additional paid in capital | 1,552 | 1,523 | 1,509 | 1,495 | 1,458 | |||
| Accumulated other comprehensive income | 238 | 29 | 68 | 119 | 194 | |||
| Retained earnings | 15,267 | 15,094 | 14,806 | 16,290 | 22,580 | |||
| Total stockholders' equity: | 16,558 | 16,149 | 15,895 | 17,431 | 23,841 | |||
| TOTAL LIABILITIES AND EQUITY: | 20,651 | 20,329 | 20,161 | 22,074 | 28,595 | |||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 10/31/2022 Q4 | 7/31/2022 Q3 | 4/30/2022 Q2 | 1/31/2022 Q1 | 10/31/2021 Q4 | 7/31/2021 Q3 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 4,638 | 4,774 | 4,967 | 5,019 | 4,988 | ||
| Cost of revenue | (3,530) | (3,462) | (3,751) | (3,775) | (3,733) | ||
| Gross profit: | 1,109 | 1,312 | 1,216 | 1,245 | 1,255 | ||
| Operating expenses | (940) | (943) | (935) | (889) | (895) | ||
| Operating income: | 169 | 370 | 281 | 356 | 360 | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 62 | (54) | 4 | 1 | 1,953 | ||
| Income from continuing operations before income taxes: | 231 | 316 | 285 | 356 | 2,313 | ||
| Income tax expense | (58) | (28) | (45) | (51) | (38) | ||
| Net income available to common stockholders, diluted: | 173 | 288 | 240 | 305 | 2,275 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 10/31/2022 Q4 | 7/31/2022 Q3 | 4/30/2022 Q2 | 1/31/2022 Q1 | 10/31/2021 Q4 | 7/31/2021 Q3 | ||
|---|---|---|---|---|---|---|---|
| Net income: | 173 | 288 | 240 | 305 | 2,275 | ||
| Comprehensive income: | 173 | 288 | 240 | 305 | 2,275 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 210 | (39) | (51) | (25) | 5 | ||
| Comprehensive income, net of tax, attributable to parent: | 383 | 249 | 189 | 280 | 2,280 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.